HomeALLO • NASDAQ
add
Allogene Therapeutics Inc
Previous close
$1.42
Day range
$1.31 - $1.49
Year range
$0.86 - $3.78
Market cap
328.11M USD
Avg Volume
2.47M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 13.74M | -15.89% |
Net income | -41.40M | 37.55% |
Net profit margin | — | — |
Earnings per share | -0.19 | 28.46% |
EBITDA | -41.80M | 27.72% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 252.19M | -13.50% |
Total assets | 439.77M | -25.35% |
Total liabilities | 124.44M | -0.74% |
Total equity | 315.33M | — |
Shares outstanding | 224.73M | — |
Price to book | 1.01 | — |
Return on assets | -24.66% | — |
Return on capital | -26.98% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -41.40M | 37.55% |
Cash from operations | -29.69M | 32.70% |
Cash from investing | 11.94M | 115.71% |
Cash from financing | 3.24M | 376.58% |
Net change in cash | -14.52M | 87.84% |
Free cash flow | -15.86M | 41.94% |
About
Founded
2017
Headquarters
Website
Employees
226
